A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

NCT00106834 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
378
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Centocor, Inc.